Back to MW MARSHALL WACE, LLP

MBXMBX
6 quarters

Position history for MWMARSHALL WACE, LLP's holdings in MBX Biosciences, Inc.

MARSHALL WACE, LLP holds 401,885 shares of MBX (MBX Biosciences, Inc.), worth $22.2M as of 2026-Q2. The position was increased (+540.9% shares). MBX represents 0.0% of MARSHALL WACE, LLP's portfolio.

Current Value

$22.2M

Current Shares

401,885

Total Value Change

+$21.9M

Total Shares Change

+389,885

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
401,885
+540.9%
$22.2M0.0%$55.20
46
2026-Q1
New
62,703
-
$1.9M0.0%$30.54
36
2025-Q2
Exited
0
-100.0%
$00.0%$10.75
0
2025-Q1
Increased
111,211
+329.4%
$820,7390.0%$7.76
40
2024-Q4
Increased
25,900
+115.8%
$477,3390.0%$17.91
39
2024-Q3
New
12,000
-
$311,7600.0%$23.95
32

Other major holders of MBX: FMR LLC, WELLINGTON MANAGEMENT GROUP LLP, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used